Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CEPH - CEPHALON -- Ignore unavailable to you. Want to Upgrade?

To: Icebrg who wrote (65)	9/22/2003 8:48:10 AM
From: Icebrg	Read Replies (1) \| Respond to of 109

2:27 pm Cephalon upgraded at Leerink Swann (CEPH) 48.71: Leerink Swann upgrades to Mkt Perform from Underperform, saying consultants believe the co's Provigil sNDA will get a positive review by an FDA advisory panel on Thursday; in addition, off-label usage for Provigil as well as prospects for label expansion (sleep apnea, excessive daytime sleepiness, fatigue, etc) could drive additional rev growth over the next few years. Interesting with an upgrade before the meeting. Let's hope they are right. Erik